Drugs / LM-305
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05647512 | Jan 2023 → Dec 2024 | plasma cell myeloma | LaNova Medicines Limited | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LM-305 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05647512 ↗ |
| Route | Intravenous | “Administered intravenously” NCT05647512 ↗ |